X-77683151-T-C
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000489.6(ATRX):c.2105A>G(p.Asn702Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000538 in 1,208,778 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N702D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000489.6 missense
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia-X-linked intellectual disability syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- ATR-X-related syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- intellectual disability-hypotonic facies syndrome, X-linked, 1Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000489.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATRX | NM_000489.6 | MANE Select | c.2105A>G | p.Asn702Ser | missense | Exon 9 of 35 | NP_000480.3 | ||
| ATRX | NM_138270.5 | c.1991A>G | p.Asn664Ser | missense | Exon 8 of 34 | NP_612114.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATRX | ENST00000373344.11 | TSL:1 MANE Select | c.2105A>G | p.Asn702Ser | missense | Exon 9 of 35 | ENSP00000362441.4 | ||
| ATRX | ENST00000395603.7 | TSL:1 | c.1991A>G | p.Asn664Ser | missense | Exon 8 of 34 | ENSP00000378967.3 | ||
| ATRX | ENST00000624166.3 | TSL:1 | c.1901A>G | p.Asn634Ser | missense | Exon 9 of 14 | ENSP00000485103.1 |
Frequencies
GnomAD3 genomes AF: 0.0000627 AC: 7AN: 111611Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000219 AC: 4AN: 182540 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000529 AC: 58AN: 1097167Hom.: 0 Cov.: 33 AF XY: 0.0000496 AC XY: 18AN XY: 362621 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000627 AC: 7AN: 111611Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33799 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1Benign:1
Inborn genetic diseases Uncertain:1
The c.2105A>G (p.N702S) alteration is located in exon 9 (coding exon 9) of the ATRX gene. This alteration results from a A to G substitution at nucleotide position 2105, causing the asparagine (N) at amino acid position 702 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at